Lawsuit Overview
An investor of Allergan, Inc. (NYSE:AGN) has filed a lawsuit alleging breaches of fiduciary duty by members of Allergan 's board in effort to have them shoulder the burden of a $600million settlement with the Department of Justice over off-label uses of its Botox drug. Allergan, Inc, located in Irvine, California, is a multi-specialty health care company focused on developing and com...
You must register (for free) or login to view the entire case.